A randomized controlled clinical trial on the treatment of Thymosin a1 versus interferon-alpha in patients with hepatitis B

World J Gastroenterol. 2001 Jun;7(3):411-4. doi: 10.3748/wjg.v7.i3.411.

Authors

J You¹, L Zhuang, B Z Tang, W B Yang, S Y Ding, W Li, R X Wu, H L Zhang, Y M Zhang, S M Yan, L Zhang

Affiliation

¹ Department of Infectious Diseases, The First Affiliated Hospital of Kunming Medical College, 153# Xi Chang Road, Kunming 650032, Yunnan Province, China.

No abstract available

Publication types

Clinical Trial
Comparative Study
Randomized Controlled Trial

MeSH terms

Adjuvants, Immunologic / administration & dosage*
Adolescent
Adult
Antiviral Agents / administration & dosage*
Antiviral Agents / adverse effects
Hepatitis B, Chronic / drug therapy*
Humans
Interferon-alpha / administration & dosage*
Interferon-alpha / adverse effects
Middle Aged
Thymalfasin
Thymosin / administration & dosage*
Thymosin / analogs & derivatives*
Treatment Outcome

Substances

Adjuvants, Immunologic
Antiviral Agents
Interferon-alpha
Thymosin
Thymalfasin